Aaro LA, Symmonds RE, Dockerty MB (1966) Sarcoma of the uterus. A clinical and pathologic study of 177 cases. Am J Obstet Gynecol 94: 101-9
Anderson TM, Mc Mahon JJ, Nwogu CE, et al. (1991) Pulmonary resection in metastatic uterine and cervical malignancies. Gynecol Oncol 83: 472-6
Gerszten K, Faul C, Kounelis S, et al. (1998) The impact of adjuvant radiotherapy on carcinosarcoma of the uterus. Gynecol Oncol 68: 8-13
Hensley ML, Maki R (2002) Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol 20 (12): 2824-31
Muss HB, Bundy B, DiSaia PJ, et al. (1985) Treatment of recurrent or advanced uterine sarcoma: A randomized trial of Doxorubicine versus Doxorubicine and Cyclophosphamide (a phase III trial of the Gynecologic Oncology Group). Cancer 55: 1648-53
No author listed (1998) Practice guidelines: uterine corpus-sarcomas. Society of Gynecologic Oncologists Clinical Practice Guidelines. Oncology (Huntingt) 12: 284-6
Omura GA, Blessing JA, Major F, et al. (1985) Randomized clinical trial of adjuvant Adriamycine in uterine sarcomas. A gynecologic oncologic group study. J Clin Oncol 3: 1240-5
Pautier P, Genestie C, Fizazi K, et al. (2002) Cisplatin-based chemotherapy regimen (DECAV) for uterine sarcomas. Int J Gynecol Cancer 12 (6): 749-54
Shimm DS, Bell DA, Fuller AF, et al. (1984) Sarcomas of the uterine corpus: prognostic factors and treatment. Radioth Oncol 2: 201-7
Sorbe B (1985) Radiotherapy and/or chemotherapy as adjuvant treatment of uterine sarcomas. Gynecol Oncol 20: 281-9
